Spectrum Pharmaceuticals CEO Joseph Turgeon's 2019 pay jumps 21% to $5.7M
Spectrum Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 22, 2020
Spectrum Pharmaceuticals reported fiscal year 2019 executive compensation information on April 22, 2020.
In 2019, five executives at Spectrum Pharmaceuticals received on average a compensation package of $3.7M, a 17% decrease compared to previous year.
Average pay of disclosed executives at Spectrum Pharmaceuticals
Joseph W. Turgeon, Chief Executive Officer, received $5.7M in total, which increased by 21% compared to 2018. 53% of Turgeon's compensation, or $3M, was in stock awards. Turgeon also received $499K in bonus, $1.3M in option awards, $750K in salary, as well as $148K in other compensation.
For fiscal year 2019, the median employee pay was $145,453 at Spectrum Pharmaceuticals. Therefore, the ratio of Joseph W. Turgeon's pay to the median employee pay was 39 to one.
Thomas J. Riga, Chief Operating Officer, received a compensation package of $3.8M, which decreased by 28% compared to previous year. 52% of the compensation package, or $2M, was in stock awards.
Kurt A. Gustafson, Chief Financial Officer, earned $3.1M in 2019, a 21% increase compared to previous year.
Keith M. McGahan, Chief Legal Officer, received $3M in 2019, which decreases by 41% compared to 2018.
Francois J. Lebel, Chief Medical Officer, earned $2.7M in 2019.
Related executives
Joseph Turgeon
Spectrum Pharmaceuticals
Chief Executive Officer
Kurt Gustafson
Spectrum Pharmaceuticals
Chief Financial Officer
Francois Lebel
Spectrum Pharmaceuticals
Chief Medical Officer
Keith McGahan
Spectrum Pharmaceuticals
Chief Legal Officer
Thomas Riga
Spectrum Pharmaceuticals
Chief Executive Officer
You may also like
Source: SEC filing on April 22, 2020.